Literature DB >> 22793028

Simultaneous LC-MS/MS quantitation of acetaminophen and its glucuronide and sulfate metabolites in human dried blood spot samples collected by subjects in a pilot clinical study.

Wenkui Li1, John P Doherty, Kenneth Kulmatycki, Harold T Smith, Francis Ls Tse.   

Abstract

BACKGROUND: In support of a pilot clinical trial using acetaminophen as the model compound to assess dried blood spot (DBS) sampling as the method for clinical pharmacokinetic sample collection, a novel sensitive LC-MS/MS method was developed and validated for the simultaneous determination of acetaminophen and its major metabolites, acetaminophen glucuronide and sulfate, in human DBS samples collected by subjects via fingerprick.
RESULTS: The validated assay dynamic range was from 50.0 to 5000 ng/ml for each compound using a 1/8´´ (3-mm) disc punched from a DBS sample. Baseline separation of the three analytes was achieved to eliminate the possible impact of insource fragmentation of the conjugated metabolites on the analysis of the parent. The overall extraction efficiency was from 61.3 to 78.8% for the three analytes by direct extraction using methanol.
CONCLUSION: The validated method was successfully implemented in the pilot clinical study with the obtained pharmacokinetic parameters in agreement with the values reported in literature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22793028     DOI: 10.4155/bio.12.119

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  4 in total

1.  Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Rachel R Taylor; Keith L Hoffman; Björn Schniedewind; Claudia Clavijo; Jeffrey L Galinkin; Uwe Christians
Journal:  J Pharm Biomed Anal       Date:  2013-04-16       Impact factor: 3.935

Review 2.  Emerging trends in paper spray mass spectrometry: Microsampling, storage, direct analysis, and applications.

Authors:  Benjamin S Frey; Deidre E Damon; Abraham K Badu-Tawiah
Journal:  Mass Spectrom Rev       Date:  2019-09-06       Impact factor: 10.946

Review 3.  Therapeutic drug monitoring by dried blood spot: progress to date and future directions.

Authors:  Abraham J Wilhelm; Jeroen C G den Burger; Eleonora L Swart
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

4.  Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process.

Authors:  Rosita Zakaria; Katrina J Allen; Jennifer J Koplin; Peter Roche; Ronda F Greaves
Journal:  EJIFCC       Date:  2016-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.